About The Concinnity Company
Cloud Concinnity is software that runs the operational work around clinical trials. It covers committees such as data monitoring committees and steering committees. Teams design their own workflows with no-code configuration. Each approval and decision goes into an automatic audit trail. The platform works alongside a team's existing systems of record instead of replacing them. It is validated under 21 CFR Part 11 and sold to trial sponsors, contract research organizations, and academic medical centers.
The company is based in Nashville, Tennessee. Nancy Falls is co-founder and chief executive officer. Heidi Solomon Allen is co-founder and chief development and legal officer. Michael Lalor is chief financial and administrative officer, Matthew Cook is chief technology officer, and Sarah McNew Razzaque is chief product officer. The REACH Trial and Coordinating Center uses the platform. Clinical teams report time savings of 50% or more.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Oct 22, 2026 | $750,001of $1.0M target | 7 | $107K | EquityRule 506(b) | Form D ↗ |
| Mar 9, 2019 | Jun 25, 2019 | $836,175fully sold | 11 | $76,016 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $1,586,176 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Why Investors Backed The Concinnity Company
Cloud Concinnity, Inc. makes software that manages committee work and regulated workflows in clinical trials. The Nashville company was co-founded by Nancy Falls, its chief executive officer, and Heidi Solomon Allen. It has announced work with the REACH Trial and Coordinating Center and with Cancer Research And Biostatistics.
The problem it targets
The company's case is that investigator-initiated trials, run by academic researchers, have few services for managing oversight. These teams must coordinate several oversight bodies, manage sensitive data, and meet regulatory rules for safety committees. The company adds that regulated work often runs across email threads and spreadsheets instead of a controlled process.
What the product does
Each customer gets a pre-configured, validated workspace. The company handles platform configuration and GxP validation, and onboarding takes 30 days. Workspaces differ by buyer. Sponsors get independent oversight models, CROs get tools that add capacity, and academic medical centers get committee-based governance. The product is organized around four pillars: control, oversight, capacity, and inspection-readiness.
Progress so far
The company announced on November 25, 2025 that the REACH Trial and Coordinating Center uses Cloud Concinnity. The center applies it to data monitoring, steering, and operations committees. On May 20, 2021, the company announced a partnership with Cancer Research And Biostatistics on data monitoring committees. It released version 3.2.0 in November 2024. The company also lists a clinical trial advisory council and an advisory board. Members include Dr. Susan Alpert, a medical device and regulatory expert, and Townes Duncan, a general partner at Invergarry Holdings.
We wrote this summary from public statements by The Concinnity Company and its investors. It is not investment advice.
The Concinnity Company in the News
Leadership Team
Executive officers and directors listed on The Concinnity Company's Form D filed Oct 22, 2026.
